sotalol has been researched along with Postoperative Complications in 34 studies
Sotalol: An adrenergic beta-antagonist that is used in the treatment of life-threatening arrhythmias.
sotalol : A sulfonamide that is N-phenylmethanesulfonamide in which the phenyl group is substituted at position 4 by a 1-hydroxy-2-(isopropylamino)ethyl group. It has both beta-adrenoreceptor blocking (Vaughan Williams Class II) and cardiac action potential duration prolongation (Vaughan Williams Class III) antiarrhythmic properties. It is used (usually as the hydrochloride salt) for the management of ventricular and supraventricular arrhythmias.
Postoperative Complications: Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Oral low-dose sotalol provides a considerable reduction in the occurrence of atrial fibrillation." | 9.11 | Preoperative use of sotalol versus atenolol for atrial fibrillation after cardiac surgery. ( Blasco, M; Carbonell, N; Jordá, A; Martínez-León, J; Núñez, J; Otero, E; Sanjuán, R, 2004) |
| "These results show that MgCl(2), in addition to sotalol, is not more effective than sotalol alone in the prevention of tachyarrhythmias after CABG." | 9.11 | Magnesium in addition to sotalol does not influence the incidence of postoperative atrial tachyarrhythmias after coronary artery bypass surgery. ( Beukema, WP; Geertman, H; Sie, HT; van der Starre, PJ; van Rooyen-Butijn, M, 2004) |
| "This prospective, randomized, double-blind, placebo-controlled study compared the efficacy and safety of amiodarone and sotalol in the prevention of atrial fibrillation (AF) following open heart surgery." | 9.11 | Amiodarone versus sotalol for the treatment of atrial fibrillation after open heart surgery: the Reduction in Postoperative Cardiovascular Arrhythmic Events (REDUCE) trial. ( Arcidi, JM; Hilleman, DE; Lenz, TL; Mohiuddin, SM; Mooss, AN; Packard, KA; Rovang, KS; Sugimoto, JT; Wurdeman, RL, 2004) |
| "The purpose of this prospective, randomized, double-blind, placebo-controlled study was to assess the efficacy of preoperatively and postoperatively administered oral d,l sotalol in preventing the occurrence of postoperative atrial fibrillation (AF)." | 9.09 | Oral d,l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patients: a randomized, double-blind, placebo-controlled study. ( Chao, S; Ergin, A; Gomes, JA; Ip, J; Lansman, S; Mehta, D; Newhouse, TT; Pe, E; Santoni-Rugiu, F, 1999) |
| "We assessed the efficacy of postoperatively administered oral Sotalol in preventing the occurrence of postoperative atrial fibrillation." | 9.09 | Effect of Sotalol in the prevention of atrial fibrillation following coronary artery bypass grafting. ( Ishida, K; Matsuura, K; Sudo, Y; Takahara, Y, 2001) |
| "Thus, a selective approach based on a clinical risk prediction algorithm should improve the cost-effectiveness and safety of low-dose sotalol in the prevention of atrial fibrillation after coronary bypass surgery." | 9.08 | Selective versus non-selective antiarrhythmic approach for prevention of atrial fibrillation after coronary surgery: is there a need for pre-operative risk stratification? A prospective placebo-controlled study using low-dose sotalol. ( Buser, P; Huber, M; Osswald, S; Pfisterer, M; Schmidhauser, C; Skarvan, K; Stulz, P; Weber, UK, 1998) |
| "The efficacy of sotalol in treating acute atrial fibrillation and flutter after open heart surgery was compared with that of a digoxin/disopyramide combination." | 9.05 | Intravenous sotalol for the treatment of atrial fibrillation and flutter after cardiopulmonary bypass. Comparison with disopyramide and digoxin in a randomised trial. ( Campbell, TJ; Gavaghan, TP; Morgan, JJ, 1985) |
| "This study describes the efficacy of oral sotalol in the treatment and prevention of atrial flutter in children after surgery for congenital heart disease." | 7.69 | Effectiveness of sotalol for atrial flutter in children after surgery for congenital heart disease. ( Beaufort-Krol, GC; Bink-Boelkens, MT, 1997) |
| "Sotalol was effective in reducing the incidence of atrial fibrillation." | 6.67 | Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypass surgery. ( Berggren, H; Edvardsson, N; Nyström, U; Pizzarelli, GP; Rådegran, K, 1993) |
| "Both amiodarone and sotalol were more effective than placebo treatment in reducing the incidence of postoperative AFF." | 6.41 | Amiodarone vs. sotalol as prophylaxis against atrial fibrillation/flutter after heart surgery: a meta-analysis. ( Lenz, TL; Mohiuddin, SM; Mooss, AN; Wurdeman, RL, 2002) |
| " Conversion to sinus rhythm was achieved in 16 out of 22 hemodynamically stable children with a dosage of 4." | 5.30 | Sotalol for atrial tachycardias after surgery for congenital heart disease. ( Beaufort-Krol, GC; Bink-Boelkens, MT, 1997) |
| "Oral low-dose sotalol provides a considerable reduction in the occurrence of atrial fibrillation." | 5.11 | Preoperative use of sotalol versus atenolol for atrial fibrillation after cardiac surgery. ( Blasco, M; Carbonell, N; Jordá, A; Martínez-León, J; Núñez, J; Otero, E; Sanjuán, R, 2004) |
| "Atrial fibrillation (AF) frequently occurs after cardiac surgical procedures, and beta-blockers, sotalol, and amiodarone may reduce the frequency of AF after open heart surgery." | 5.11 | A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SPPAF), a randomized, placebo-controlled trial. ( Auer, J; Berent, R; Eber, B; Hartl, P; Lamm, G; Lassnig, E; Lehner, E; Ng, CK; Puschmann, R; Schwarz, C; Strasser, U; Weber, T, 2004) |
| "These results show that MgCl(2), in addition to sotalol, is not more effective than sotalol alone in the prevention of tachyarrhythmias after CABG." | 5.11 | Magnesium in addition to sotalol does not influence the incidence of postoperative atrial tachyarrhythmias after coronary artery bypass surgery. ( Beukema, WP; Geertman, H; Sie, HT; van der Starre, PJ; van Rooyen-Butijn, M, 2004) |
| "This prospective, randomized, double-blind, placebo-controlled study compared the efficacy and safety of amiodarone and sotalol in the prevention of atrial fibrillation (AF) following open heart surgery." | 5.11 | Amiodarone versus sotalol for the treatment of atrial fibrillation after open heart surgery: the Reduction in Postoperative Cardiovascular Arrhythmic Events (REDUCE) trial. ( Arcidi, JM; Hilleman, DE; Lenz, TL; Mohiuddin, SM; Mooss, AN; Packard, KA; Rovang, KS; Sugimoto, JT; Wurdeman, RL, 2004) |
| "The purpose of this prospective, randomized, double-blind, placebo-controlled study was to assess the efficacy of preoperatively and postoperatively administered oral d,l sotalol in preventing the occurrence of postoperative atrial fibrillation (AF)." | 5.09 | Oral d,l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patients: a randomized, double-blind, placebo-controlled study. ( Chao, S; Ergin, A; Gomes, JA; Ip, J; Lansman, S; Mehta, D; Newhouse, TT; Pe, E; Santoni-Rugiu, F, 1999) |
| "We assessed the efficacy of postoperatively administered oral Sotalol in preventing the occurrence of postoperative atrial fibrillation." | 5.09 | Effect of Sotalol in the prevention of atrial fibrillation following coronary artery bypass grafting. ( Ishida, K; Matsuura, K; Sudo, Y; Takahara, Y, 2001) |
| "Thus, a selective approach based on a clinical risk prediction algorithm should improve the cost-effectiveness and safety of low-dose sotalol in the prevention of atrial fibrillation after coronary bypass surgery." | 5.08 | Selective versus non-selective antiarrhythmic approach for prevention of atrial fibrillation after coronary surgery: is there a need for pre-operative risk stratification? A prospective placebo-controlled study using low-dose sotalol. ( Buser, P; Huber, M; Osswald, S; Pfisterer, M; Schmidhauser, C; Skarvan, K; Stulz, P; Weber, UK, 1998) |
| "The efficacy of sotalol in treating acute atrial fibrillation and flutter after open heart surgery was compared with that of a digoxin/disopyramide combination." | 5.05 | Intravenous sotalol for the treatment of atrial fibrillation and flutter after cardiopulmonary bypass. Comparison with disopyramide and digoxin in a randomised trial. ( Campbell, TJ; Gavaghan, TP; Morgan, JJ, 1985) |
| "This study describes the efficacy of oral sotalol in the treatment and prevention of atrial flutter in children after surgery for congenital heart disease." | 3.69 | Effectiveness of sotalol for atrial flutter in children after surgery for congenital heart disease. ( Beaufort-Krol, GC; Bink-Boelkens, MT, 1997) |
| "Propafenone was given to Group 1 (G1); sotalol to Group 2 (G2); amiodarone to Group 3 (G3) and diltiazem to Group 4 (G4) at doses of 300 mg/day, 80 mg/day, 400 mg/day and 180 mg/day orally respectively." | 2.73 | [The comparison between the efficiency of different anti-arrhythmic agents in preventing postoperative atrial fibrillation after open heart surgery]. ( Aytekin, S; Aytekin, V; Men, EE; Tuğcu, A; Yildirimtürk, O, 2008) |
| "Many patients with paroxysmal atrial fibrillation (AF) become refractory to antiarrhythmic drugs (AADs)." | 2.71 | Hybrid therapy with right atrial catheter ablation and previously ineffective antiarrhythmic drugs for the management of atrial fibrillation. ( Block, JE; Calkins, H; Cher, D; Kocheril, AG; Sharma, AD; Stubbs, HA, 2005) |
| "Sotalol was effective in reducing the incidence of atrial fibrillation." | 2.67 | Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypass surgery. ( Berggren, H; Edvardsson, N; Nyström, U; Pizzarelli, GP; Rådegran, K, 1993) |
| "Atrial fibrillation is the most common arrhythmia encountered postoperatively, although ventricular arrhythmias and conduction disturbances can also occur." | 2.41 | Cardiac surgery: postoperative arrhythmias. ( Chung, MK, 2000) |
| "Both amiodarone and sotalol were more effective than placebo treatment in reducing the incidence of postoperative AFF." | 2.41 | Amiodarone vs. sotalol as prophylaxis against atrial fibrillation/flutter after heart surgery: a meta-analysis. ( Lenz, TL; Mohiuddin, SM; Mooss, AN; Wurdeman, RL, 2002) |
| "Sotalol has a rapid onset of action, allowing it to be efficacious when used orally shortly after surgery." | 2.40 | Prevention of atrial fibrillation in the postoperative cardiac patient: significance of oral class III antiarrhythmic agents. ( Morady, F, 1999) |
| " Conversion to sinus rhythm was achieved in 16 out of 22 hemodynamically stable children with a dosage of 4." | 1.30 | Sotalol for atrial tachycardias after surgery for congenital heart disease. ( Beaufort-Krol, GC; Bink-Boelkens, MT, 1997) |
| "Sotalol was administered to 32 patients with a mean age of 8." | 1.29 | [Results of oral sotalol therapy in children with supraventricular and ventricular arrhythmias]. ( Kallfelz, HC; Lehmann, C; Paul, T; Pfammatter, JP, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.94) | 18.7374 |
| 1990's | 10 (29.41) | 18.2507 |
| 2000's | 21 (61.76) | 29.6817 |
| 2010's | 2 (5.88) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dobrev, D | 1 |
| Aguilar, M | 1 |
| Heijman, J | 1 |
| Guichard, JB | 1 |
| Nattel, S | 1 |
| Men, EE | 1 |
| Yildirimtürk, O | 1 |
| Tuğcu, A | 1 |
| Aytekin, V | 1 |
| Aytekin, S | 1 |
| Kerin, NZ | 1 |
| Jacob, S | 1 |
| Forlani, S | 2 |
| De Paulis, R | 1 |
| de Notaris, S | 1 |
| Nardi, P | 1 |
| Tomai, F | 1 |
| Proietti, I | 1 |
| Ghini, AS | 1 |
| Chiariello, L | 2 |
| Zimmer, J | 1 |
| Pezzullo, J | 1 |
| Choucair, W | 1 |
| Southard, J | 1 |
| Kokkinos, P | 1 |
| Karasik, P | 1 |
| Greenberg, MD | 1 |
| Singh, SN | 1 |
| Scherer, M | 1 |
| Dzemali, O | 1 |
| Aybek, T | 1 |
| Wimmer-Greinecker, G | 1 |
| Moritz, A | 1 |
| Moscarelli, M | 1 |
| Scafuri, A | 1 |
| Pellegrino, A | 1 |
| Lee, JK | 1 |
| Klein, GJ | 1 |
| Krahn, AD | 1 |
| Yee, R | 1 |
| Zarnke, K | 1 |
| Simpson, C | 1 |
| Skanes, A | 1 |
| Crystal, E | 2 |
| Healey, J | 1 |
| Connolly, SJ | 1 |
| Sanjuán, R | 1 |
| Blasco, M | 1 |
| Carbonell, N | 1 |
| Jordá, A | 1 |
| Núñez, J | 1 |
| Martínez-León, J | 1 |
| Otero, E | 1 |
| Auer, J | 1 |
| Weber, T | 1 |
| Berent, R | 1 |
| Puschmann, R | 1 |
| Hartl, P | 1 |
| Ng, CK | 1 |
| Schwarz, C | 1 |
| Lehner, E | 1 |
| Strasser, U | 1 |
| Lassnig, E | 1 |
| Lamm, G | 1 |
| Eber, B | 1 |
| Jayatilleke, I | 1 |
| Doolan, A | 1 |
| Ingles, J | 1 |
| McGuire, M | 1 |
| Booth, V | 1 |
| Richmond, DR | 1 |
| Semsarian, C | 1 |
| Geertman, H | 1 |
| van der Starre, PJ | 1 |
| Sie, HT | 1 |
| Beukema, WP | 1 |
| van Rooyen-Butijn, M | 1 |
| Mooss, AN | 2 |
| Wurdeman, RL | 2 |
| Sugimoto, JT | 1 |
| Packard, KA | 1 |
| Hilleman, DE | 1 |
| Lenz, TL | 2 |
| Rovang, KS | 1 |
| Arcidi, JM | 1 |
| Mohiuddin, SM | 2 |
| Kocheril, AG | 1 |
| Calkins, H | 1 |
| Sharma, AD | 1 |
| Cher, D | 1 |
| Stubbs, HA | 1 |
| Block, JE | 1 |
| Shantsila, E | 1 |
| Watson, T | 1 |
| Lip, GY | 1 |
| Iwamoto, J | 1 |
| Inoue, H | 1 |
| Berdajs, D | 1 |
| Schurr, UP | 1 |
| Wagner, A | 1 |
| Seifert, B | 1 |
| Turina, MI | 1 |
| Genoni, M | 1 |
| Paul, T | 1 |
| Lehmann, C | 1 |
| Pfammatter, JP | 1 |
| Kallfelz, HC | 1 |
| Nyström, U | 1 |
| Edvardsson, N | 1 |
| Berggren, H | 1 |
| Pizzarelli, GP | 1 |
| Rådegran, K | 1 |
| Pearce, SH | 1 |
| Rees, CJ | 1 |
| Smith, RH | 1 |
| Beaufort-Krol, GC | 2 |
| Bink-Boelkens, MT | 2 |
| Pfisterer, ME | 1 |
| Klöter-Weber, UC | 1 |
| Huber, M | 2 |
| Osswald, S | 2 |
| Buser, PT | 1 |
| Skarvan, K | 2 |
| Stulz, PM | 1 |
| Weber, UK | 1 |
| Buser, P | 1 |
| Stulz, P | 1 |
| Schmidhauser, C | 1 |
| Pfisterer, M | 1 |
| Gomes, JA | 1 |
| Ip, J | 1 |
| Santoni-Rugiu, F | 1 |
| Mehta, D | 1 |
| Ergin, A | 1 |
| Lansman, S | 1 |
| Pe, E | 1 |
| Newhouse, TT | 1 |
| Chao, S | 1 |
| Morady, F | 1 |
| Bharucha, DB | 1 |
| Kowey, PR | 1 |
| Chung, MK | 1 |
| Matsuura, K | 1 |
| Takahara, Y | 1 |
| Sudo, Y | 1 |
| Ishida, K | 1 |
| Konertz, W | 1 |
| Weyand, M | 1 |
| Deiwick, M | 1 |
| Scheld, HH | 1 |
| Campbell, TJ | 1 |
| Gavaghan, TP | 1 |
| Morgan, JJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Association of Postoperative Lactate Levels With Postoperative Atrial Fibrillation in Patients Undergoing Isolated Coronary Artery Bypass Graft Surgery[NCT05448521] | 250 participants (Anticipated) | Observational | 2022-08-15 | Recruiting | |||
| Statin Therapy With Atorvastatin in Surgical Aortic Valve Replacement - a Randomized Controlled Trial[NCT05076019] | 266 participants (Anticipated) | Interventional | 2022-02-01 | Recruiting | |||
| Post-Operative Atrial Fibrillation After Surgical Aortic Valve Replacement and the Influence of Statins - Randomized Controlled Trial[NCT05062239] | 100 participants (Anticipated) | Interventional | 2022-04-01 | Recruiting | |||
| A Randomized Controlled Trial of Prophylactic Pulmonary Vein Isolation as Adjunct to Coronary Artery Bypass Grafting[NCT00338715] | Phase 3 | 193 participants (Actual) | Interventional | 2006-07-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
11 reviews available for sotalol and Postoperative Complications
| Article | Year |
|---|---|
Postoperative atrial fibrillation: mechanisms, manifestations and management.
Topics: Adrenergic beta-Antagonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Calci | 2019 |
Postoperative atrial fibrillation: mechanisms, manifestations and management.
Topics: Adrenergic beta-Antagonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Calci | 2019 |
Postoperative atrial fibrillation: mechanisms, manifestations and management.
Topics: Adrenergic beta-Antagonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Calci | 2019 |
Postoperative atrial fibrillation: mechanisms, manifestations and management.
Topics: Adrenergic beta-Antagonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Calci | 2019 |
Postoperative atrial fibrillation: mechanisms, manifestations and management.
Topics: Adrenergic beta-Antagonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Calci | 2019 |
Postoperative atrial fibrillation: mechanisms, manifestations and management.
Topics: Adrenergic beta-Antagonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Calci | 2019 |
Postoperative atrial fibrillation: mechanisms, manifestations and management.
Topics: Adrenergic beta-Antagonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Calci | 2019 |
Postoperative atrial fibrillation: mechanisms, manifestations and management.
Topics: Adrenergic beta-Antagonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Calci | 2019 |
Postoperative atrial fibrillation: mechanisms, manifestations and management.
Topics: Adrenergic beta-Antagonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Calci | 2019 |
The efficacy of sotalol in preventing postoperative atrial fibrillation: a meta-analysis.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Double-Blind Method; Drug Therapy, Combination; Electro | 2011 |
Meta-analysis of antiarrhythmic therapy in the prevention of postoperative atrial fibrillation and the effect on hospital length of stay, costs, cerebrovascular accidents, and mortality in patients undergoing cardiac surgery.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Cardiac Surgica | 2003 |
Atrial fibrillation after cardiac surgery: update on the evidence on the available prophylactic interventions.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing | 2003 |
Atrial fibrillation after cardiac surgery: evidence on prophylactic interventions.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing | 2003 |
Atrial fibrillation post-cardiac surgery: changing perspectives.
Topics: Amiodarone; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Atrial Fibrillation; Cardiac Surgical | 2006 |
[Pharmacological therapy for atrial fibrillation after cardiac surgery].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anticoagulants; Atrial Fibrillation; Calcium Channel Blocke | 2007 |
Prevention of atrial fibrillation in the postoperative cardiac patient: significance of oral class III antiarrhythmic agents.
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Clinical Trials as To | 1999 |
Management and prevention of atrial fibrillation after cardiovascular surgery.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial | 2000 |
Cardiac surgery: postoperative arrhythmias.
Topics: Algorithms; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Cardiac Surgic | 2000 |
Amiodarone vs. sotalol as prophylaxis against atrial fibrillation/flutter after heart surgery: a meta-analysis.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Coronary Artery Bypas | 2002 |
15 trials available for sotalol and Postoperative Complications
| Article | Year |
|---|---|
[The comparison between the efficiency of different anti-arrhythmic agents in preventing postoperative atrial fibrillation after open heart surgery].
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgical Proc | 2008 |
Combination of sotalol and magnesium prevents atrial fibrillation after coronary artery bypass grafting.
Topics: Aged; Atrial Fibrillation; Coronary Artery Bypass; Dose-Response Relationship, Drug; Drug Administra | 2002 |
Combination therapy for prevention of atrial fibrillation after coronary artery bypass surgery: a randomized trial of sotalol and magnesium.
Topics: Adrenergic beta-Antagonists; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Artery Bypa | 2003 |
Rate-control versus conversion strategy in postoperative atrial fibrillation: trial design and pilot study results.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia, Sinus; Atrial Fib | 2003 |
Preoperative use of sotalol versus atenolol for atrial fibrillation after cardiac surgery.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Anti-Arrhythmia Agents; Atenolol; Atrial Fi | 2004 |
A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SPPAF), a randomized, placebo-controlled trial.
Topics: Administration, Oral; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgica | 2004 |
Magnesium in addition to sotalol does not influence the incidence of postoperative atrial tachyarrhythmias after coronary artery bypass surgery.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cardiopulmonary Bypass; Coronary Artery | 2004 |
Amiodarone versus sotalol for the treatment of atrial fibrillation after open heart surgery: the Reduction in Postoperative Cardiovascular Arrhythmic Events (REDUCE) trial.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgical Procedures; Coronary | 2004 |
Hybrid therapy with right atrial catheter ablation and previously ineffective antiarrhythmic drugs for the management of atrial fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Combined Modality Therap | 2005 |
Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypass surgery.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Age Factors; Aged; Atrial Fibrillation; Ch | 1993 |
Prevention of supraventricular tachyarrhythmias after open heart operation by low-dose sotalol: a prospective, double-blind, randomized, placebo-controlled study.
Topics: Aged; Anti-Arrhythmia Agents; Aortic Valve; Coronary Artery Bypass; Double-Blind Method; Female; Hea | 1997 |
Selective versus non-selective antiarrhythmic approach for prevention of atrial fibrillation after coronary surgery: is there a need for pre-operative risk stratification? A prospective placebo-controlled study using low-dose sotalol.
Topics: Adult; Aged; Algorithms; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Artery Bypass; Dose-R | 1998 |
Oral d,l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patients: a randomized, double-blind, placebo-controlled study.
Topics: Administration, Oral; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Artery Bypass; Dou | 1999 |
Effect of Sotalol in the prevention of atrial fibrillation following coronary artery bypass grafting.
Topics: Administration, Oral; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Artery Bypass; Fem | 2001 |
Intravenous sotalol for the treatment of atrial fibrillation and flutter after cardiopulmonary bypass. Comparison with disopyramide and digoxin in a randomised trial.
Topics: Atrial Fibrillation; Atrial Flutter; Cardiopulmonary Bypass; Clinical Trials as Topic; Digoxin; Diso | 1985 |
8 other studies available for sotalol and Postoperative Complications
| Article | Year |
|---|---|
Impact of left atrial size reduction on chronic atrial fibrillation in mitral valve surgery.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pac | 2003 |
Long-term follow-up of implantable cardioverter defibrillator therapy for hypertrophic cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Adult; Australia; Cardiomyopathy, Hypertrophic; Defibrillators, Implant | 2004 |
Incidence and pathophysiology of atrioventricular block following mitral valve replacement and ring annuloplasty.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arteries; Atrioventricular Block; Atrio | 2008 |
[Results of oral sotalol therapy in children with supraventricular and ventricular arrhythmias].
Topics: Administration, Oral; Adolescent; Adult; Atrial Flutter; Atrioventricular Node; Cardiac Complexes, P | 1994 |
Fetal monitoring during maternal antiarrhythmic therapy.
Topics: Adenosine; Adult; Atenolol; Cardiotocography; Drug Therapy, Combination; Female; Humans; Infant, New | 1993 |
Effectiveness of sotalol for atrial flutter in children after surgery for congenital heart disease.
Topics: Adolescent; Anti-Arrhythmia Agents; Atrial Flutter; Child; Child, Preschool; Heart Defects, Congenit | 1997 |
Sotalol for atrial tachycardias after surgery for congenital heart disease.
Topics: Administration, Oral; Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Bradycardi | 1997 |
Is pretransplant antiarrhythmic drug therapy a risk factor?
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Cause of Death; Child; Femal | 1992 |